Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00694577 · ClinicalTrials.gov registry record · NA
Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast Cancer
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 324
- Enrollment target
NCT00694577: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00694577 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 324 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00694577, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 324 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility of partial breast irradiation in participants with early invasive or non-invasive breast cancer.
Interventions
- RADIATION Partial Breast Irradiation using 32 Gy / 8 fractions
- RADIATION Partial Breast Irradiation using 36 Gy / 9 fractions
- RADIATION Partial Breast Irradiation using 40 Gy /10 fractions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2003-09 |
| Est. Completion | 2021-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00694577
The ClinicalTrials.gov registry entry for NCT00694577 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 324 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Partial Breast Irradiation using 32 Gy / 8 fractions is the first listed.
NCT00694577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00694577 about?
NCT00694577 is a clinical study titled "Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast Cancer". The purpose of this study is to determine the feasibility of partial breast irradiation in participants with early invasive or non-invasive breast cancer.
What is the current status of trial NCT00694577?
This trial is currently completed. It is a NA study. The enrollment target is 324 participants. The study started on 2003-09. Estimated completion is 2021-06.
What interventions are being tested in trial NCT00694577?
The interventions under investigation include: Partial Breast Irradiation using 32 Gy / 8 fractions (RADIATION), Partial Breast Irradiation using 36 Gy / 9 fractions (RADIATION), Partial Breast Irradiation using 40 Gy /10 fractions (RADIATION).
Who is sponsoring clinical trial NCT00694577?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.